4.72
2.61%
0.12
Handel nachbörslich:
4.70
-0.02
-0.42%
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
149.84%
17.58
|
7.038 | 13.12 | 19.79 | 8.78 |
Operating Expenses
|
0.72%
21.77
|
21.93 | 25.48 | 31.78 | 33.24 |
Interest Income/Expense |
0.86%
0.574
|
0.579 | 0.576 | 0.553 | 0.522 |
Benefits Costs and Expenses |
56.06%
8.996
|
20.47 | 25.23 | - | 33.84 |
Costs And Expenses |
56.06%
8.996
|
20.47 | 25.23 | 31.78 | 33.84 |
Depreciation and Amortization |
10.63%
1.143
|
1.279 | 1.62 | 1.965 | 1.953 |
Operating Income/Loss |
71.88%
-4.187
|
-14.89 | -12.36 | -11.99 | -24.46 |
Income/Loss Before Equity Method Investments |
154.72%
6.875
|
-12.56 | -10.76 | 21.16 | -23.72 |
Income/Loss From Equity Method Investments |
296.67%
1.713
|
-0.871 | -1.35 | -1.369 | -1.341 |
Income/Loss From Continuing Operations Before Tax |
163.93%
8.588
|
-13.43 | -12.11 | -11.89 | -25.06 |
Income/Loss From Continuing Operations After Tax |
163.93%
8.588
|
-13.43 | -12.11 | -11.89 | -25.06 |
Net Income/Loss
|
152.72%
8.588
|
-16.29 | -8.079 | -11.89 | -25.06 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
104.61%
5.061
|
-109.70 | 115.17 | 114.10 | 111.30 |
Diluted Average Shares |
104.62%
5.0634
|
-109.70 | 115.17 | 114.10 | 111.30 |
Basic Earnings Per Share |
110.93%
1.70
|
-15.56 | -0.07 | -0.10 | -0.23 |
Diluted Earnings Per Share |
110.93%
1.70
|
-15.56 | -0.07 | -0.10 | -0.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):